These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1355 related items for PubMed ID: 22801442

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Treatment of episodes of hereditary angioedema with C1 inhibitor: serial assessment of observed abnormalities of the plasma bradykinin-forming pathway and fibrinolysis.
    Joseph K, Tholanikunnel TE, Kaplan AP.
    Ann Allergy Asthma Immunol; 2010 Jan; 104(1):50-4. PubMed ID: 20143645
    [Abstract] [Full Text] [Related]

  • 5. Managing hereditary angioedema patients undergoing otolaryngeal procedures.
    Bernstein JA.
    Am J Rhinol Allergy; 2013 Jan; 27(6):522-7. PubMed ID: 23866957
    [Abstract] [Full Text] [Related]

  • 6. Pathogenic mechanisms of bradykinin mediated diseases: dysregulation of an innate inflammatory pathway.
    Kaplan AP, Joseph K.
    Adv Immunol; 2014 Jan; 121():41-89. PubMed ID: 24388213
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Hereditary and acquired angioedema.
    Patel G, Pongracic JA.
    Allergy Asthma Proc; 2019 Nov 01; 40(6):441-445. PubMed ID: 31690390
    [Abstract] [Full Text] [Related]

  • 11. Fatal laryngeal attacks and mortality in hereditary angioedema due to C1-INH deficiency.
    Bork K, Hardt J, Witzke G.
    J Allergy Clin Immunol; 2012 Sep 01; 130(3):692-7. PubMed ID: 22841766
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The safety of treatments for angioedema with hereditary C1 inhibitor deficiency.
    Zanichelli A, Wu MA, Andreoli A, Mansi M, Cicardi M.
    Expert Opin Drug Saf; 2015 Sep 01; 14(11):1725-36. PubMed ID: 26429506
    [Abstract] [Full Text] [Related]

  • 15. [Hereditary angioedema: new mechanisms and therapeutic options].
    Reshef A, Leibovich I, Goren A, Kidon M.
    Harefuah; 2009 Aug 01; 148(8):529-34, 571. PubMed ID: 19899257
    [Abstract] [Full Text] [Related]

  • 16. Hereditary angioedema in childhood: an approach to management.
    Ebo DG, Verweij MM, De Knop KJ, Hagendorens MM, Bridts CH, De Clerck LS, Stevens WJ.
    Paediatr Drugs; 2010 Aug 01; 12(4):257-68. PubMed ID: 20593909
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Current options for prophylactic treatment of hereditary angioedema in the United States: patient-based considerations.
    Gower RG, Lumry WR, Davis-Lorton MA, Johnston DT, Busse PJ.
    Allergy Asthma Proc; 2012 Aug 01; 33(3):235-40. PubMed ID: 22584192
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 68.